These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


111 related items for PubMed ID: 2082785

  • 21. [Sneddon's syndrome: review of the literature apropos of a case].
    Pellegrin JL, Montastruc M, Ferrandez D, Orgogozo JM, Leng B.
    Rev Med Interne; 1990; 11(4):313-5. PubMed ID: 2096437
    [Abstract] [Full Text] [Related]

  • 22. Sneddon's syndrome: a rare cause of diffuse vasculopathy. A case report with review of the literature.
    Boland B, Lambert M, De Ridder F, Mathurin P.
    Acta Clin Belg; 1990; 45(2):107-12. PubMed ID: 2164308
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Sneddon's syndrome.
    Scott IA, Boyle RS.
    Aust N Z J Med; 1986 Dec; 16(6):799-802. PubMed ID: 3471198
    [Abstract] [Full Text] [Related]

  • 25. [Definition of Sneddon's syndrome: a network of convolutions].
    Francès C, Piette JC.
    Ann Dermatol Venereol; 1994 Dec; 121(4):293-6. PubMed ID: 7702246
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Facioscapulohumeral dystrophy, retinal vasculature, and Sneddon's syndrome.
    Coleman RJ, Ingram DA, Swash M.
    Muscle Nerve; 1990 Aug; 13(8):759. PubMed ID: 2385262
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Sneddon's syndrome (livedo reticularis and cerebral thrombosis) with livedo vasculitis and anticardiolipin antibodies.
    Grattan CE, Burton JL, Boon AP.
    Br J Dermatol; 1989 Mar; 120(3):441-7. PubMed ID: 2636849
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Sneddon syndrome (its association with anti-cardiolipin antibodies)].
    Kalashnikova LA, Nasonov EL, Kushekbaeva AE, Gracheva LA.
    Klin Med (Mosk); 1988 Oct; 66(10):32-7. PubMed ID: 3236780
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Sneddon's syndrome and Willebrand's factor antigen].
    Kalashnikova LA, Nasonov EL, Baranov AA, Aleksandrova EN.
    Klin Med (Mosk); 1994 Oct; 72(3):29-32. PubMed ID: 7990348
    [Abstract] [Full Text] [Related]

  • 37. Immunosuppressive therapy and Sneddon's syndrome.
    Rautenberg W, Hennerici M, Aulich A, Hölzle E, Lakomek HJ.
    Lancet; 1988 Sep 10; 2(8611):629-30. PubMed ID: 2901006
    [No Abstract] [Full Text] [Related]

  • 38. [Sneddon's syndrome and antiphospholipid antibodies].
    Pérez Sempere A, Martínez Menéndez B, Bermejo F.
    Neurologia; 1992 Nov 10; 7(9):280-1. PubMed ID: 1445719
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Sneddon syndrome].
    Richard MA, Grob JJ, Durand JM, Noë C, Basseres N, Bonerandi JJ.
    Ann Dermatol Venereol; 1994 Nov 10; 121(4):331-7. PubMed ID: 7702255
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 6.